UIMA:XETRA:XETRA-UBS ETF SICAV - MSCI Europe UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 83.1

Change

-0.28 (-0.34)%

Market Cap

USD 0.24B

Volume

47.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+1.07 (+2.05%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.35 (+2.04%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.44 (+1.61%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.44 (+1.54%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.42 (+1.68%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.04 (+0.03%)

USD 102.09B
JARI:XETRA Amundi Index Solutions - Amund..

+0.86 (+1.91%)

USD 101.20B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+1.08 (+2.07%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+1.78 (+1.71%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+9.98 (+1.66%)

USD 80.38B

ETFs Containing UIMA:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.42% 38% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.42% 37% F 41% F
Trailing 12 Months  
Capital Gain 5.42% 38% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.42% 37% F 41% F
Trailing 5 Years  
Capital Gain 20.73% 50% F 54% F
Dividend Return 7.99% 49% F 37% F
Total Return 28.72% 53% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain 9.37% 63% D 63% D
Dividend Return 10.45% 66% D+ 65% D
Total Return 1.07% 73% C 52% F
Risk Return Profile  
Volatility (Standard Deviation) 11.65% 55% F 63% D
Risk Adjusted Return 89.67% 81% B- 83% B
Market Capitalization 0.24B 49% F 44% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.